The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status
Periodontal disease consists of chronic gingival inflammation characterized by both degradation of the periodontal connective tissue and alveolar bone loss. Drug therapy is used as an auxiliary treatment method in severe chronic periodontitis, aggressive periodontitis, and periodontitis-associated s...
Main Authors: | Hongyan Wang, Lisi Ai, Yu Zhang, Jyawei Cheng, Huiyuan Yu, Chen Li, Dongmei Zhang, Yaping Pan, Li Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/1805793 |
Similar Items
-
The Antimicrobial Peptide Nal-P-113 Exerts a Reparative Effect by Promoting Cell Proliferation, Migration, and Cell Cycle Progression
by: Nana Liu, et al.
Published: (2018-01-01) -
Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production
by: Hong-yan Wang, et al.
Published: (2017-08-01) -
Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains
by: Katharina Enigk, et al.
Published: (2020-01-01) -
The level of antimicrobial peptides in gingival crevicular fluid and its correlation with periodontal clinical indexes in elderly patients with type 2 diabetic periodontitis
by: ZHANG Yameng, et al.
Published: (2021-11-01) -
Salivary Antimicrobial Peptides in Early Detection of Periodontitis
by: Guliz N. eGuncu, et al.
Published: (2015-12-01)